Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-10-18
2005-10-18
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S255050, C514S275000, C514S313000, C514S336000, C514S407000, C544S332000, C544S336000, C546S159000, C546S284400, C548S371400, C549S303000, C549S321000
Reexamination Certificate
active
06956055
ABSTRACT:
The invention relates to substituted γ-lactone compounds, to methods for the production thereof, to medicaments containing these compounds and to the use of these compounds for producing medicaments.
REFERENCES:
patent: 0386839 (1997-01-01), None
patent: WO 97/12879 (1997-04-01), None
patent: WO 98/07704 (1998-02-01), None
patent: WO 98/42673 (1998-10-01), None
Huang et al, Tet. Letters, vol. 41, p. 9747-9751 (2000).
Leeson et al., “4-Amido-2carboxytetrahydrquinolines. Structure-Activity Relationships for Antagonism at the Glycine Site of the NMDA Receptor”, J. Med. Chem. 35, 1992, pp. 1954-1968.
“Synthesis And Pharmacological Properties of Derivatives Of α-Amino-β-(p-Chlorobenzoyl)-Propionic Acid And α-Amino-γ-(p-Chlorophenyl)-Tetrahydrofuran-2-One”, Zabska et al., Polish J. Pharmacol. Pharm, 1991, 43, pp. 271-280.
“Chemoenzymic Synthesis of Unnatural Amino Acids via Modified Claisen Rearrangement of Glycine Enolates. Approach to Morphine Synthesis”, Gonzalez et al., Journal of Organic Chemistry, 1997, 62(5), pp. 1194-1195.
“Friedel-Crafts Reactions Of γ-aryl-γ-lactones”, Plusquellec, Journal Chemical Research, SYNOP. 1982, pp. 46-47.
“Reactions Of Glyoxylic Acid Derivatives With Olefins: Synthesis of .Alpha.-substituted.gamma.-lactones”, Plusquellec et al., Bulletin Societe Chimique De France, 1979, No. 9-10, PT 2, pp. 552-558.
“A New Synthesis Of Amino Acids. II. Amidoalkylation of Olefins With Glyoxylic Acid Derivatives”, Ben-Ishai et al., Tetrahedron Lett. 1975, vol. 33, pp. 1533-1442.
“Amino Acid Synthesis II. Amidoalkylation Of Olefins With Glyoxylic Acid Derivatives”, Altman et al., Tetrahedron Lett. 1975, No. 43, PP. 3737-3740.
“Relationship Between the Inhibition Constant (K1) and the Concentration of Inhibitor Which Causes 50 per cent Inhibition (I50) of an Enzymatic Reaction”, Cheng et al., Biochemical Pharmacology, vol. 22, pp. 3099-3108, 1973.
2-Carboxytetrahydroquinolines. Conformational and Stereochemical Requirements for Antagonism of the Glycine Site on the NMDA Receptor, Carling et al., J. Med. Chem. 1992, 35, pp. 1942-1953.
“[3H]MDL 105,519, a High-Affinity Radioligand for the N-Methyl-D-aspartate Receptor-Associated Glycine Recognition Site”, Baron et al., Jnl of Pharm. And Experimental Therapeutics, 1996, pp. 62-68.
Englberger Werner
Przewosny Michael
Sundermann Corinna
Dentz Bernard
Grunenthal GmbH
Perman & Green, LLP.
LandOfFree
Substituted γ-lactone compounds as NMDA-antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted γ-lactone compounds as NMDA-antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted γ-lactone compounds as NMDA-antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3444222